CP
TXG icon

CenterBook Partners’s 10x Genomics TXG Stock Holding History

CenterBook Partners’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$814K Buy
+21,237
New +$557K 0.04% 402
2026
Q1 		– Sell
-230,772
Closed -$3.76M – 783
2025
Q4 		$3.76M Buy
+230,772
New +$3.49M 0.18% 155

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CenterBook Partners's TXG Position: Q2 2026 in Review

CenterBook Partners opened a new position in 10x Genomics (TXG) in Q2 2026: 21,237 shares worth $814K. The stake represents 0.04% of the portfolio and ranks #402 among its holdings. This is a return to the name: CenterBook Partners previously reported a position in TXG as recently as Q4 2025.

CenterBook Partners first reported a position in TXG in Q4 2025 and has held it in 2 quarters since. The position peaked at $3.76M in Q4 2025. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • CenterBook Partners held 21,237 shares of 10x Genomics worth $814K as of Q2 2026.
  • 10x Genomics was a new CenterBook Partners position in Q2 2026.
  • 10x Genomics made up 0.04% of CenterBook Partners's portfolio in Q2 2026, its #402 holding.
  • CenterBook Partners first reported a position in 10x Genomics in Q4 2025 and has held it in 2 quarters since.
  • CenterBook Partners's 10x Genomics position peaked at $3.76M in Q4 2025.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.